Wall Street analysts predict that Phreesia, Inc. (NYSE:PHR) will report $43.39 million in sales for the current fiscal quarter, Zacks reports. Five analysts have issued estimates for Phreesia's earnings, with estimates ranging from $40.70 million to $45.20 million. Phreesia reported sales of $33.40 million during the same quarter last year, which indicates a positive year-over-year growth rate of 29.9%. The company is expected to issue its next earnings report on Monday, June 14th.
According to Zacks, analysts expect that Phreesia will report full-year sales of $184.74 million for the current year, with estimates ranging from $181.10 million to $186.92 million. For the next financial year, analysts expect that the firm will report sales of $223.53 million, with estimates ranging from $215.30 million to $228.32 million. Zacks Investment Research's sales averages are an average based on a survey of sell-side research analysts that cover Phreesia.
Phreesia (NYSE:PHR) last issued its quarterly earnings data on Wednesday, March 31st. The company reported ($0.10) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.15) by $0.05. Phreesia had a negative return on equity of 16.07% and a negative net margin of 16.37%.
A number of research analysts recently issued reports on the stock. Needham & Company LLC raised their target price on shares of Phreesia from $60.00 to $70.00 and gave the company a "buy" rating in a research note on Thursday, January 14th. Robert W. Baird began coverage on Phreesia in a research report on Thursday, April 1st. They issued an "outperform" rating and a $60.00 price target on the stock. KeyCorp cut their price objective on Phreesia from $80.00 to $70.00 and set an "overweight" rating for the company in a research report on Wednesday, March 31st. They noted that the move was a valuation call. Piper Sandler reaffirmed an "overweight" rating and issued a $58.00 target price (up previously from $56.00) on shares of Phreesia in a report on Wednesday, March 31st. Finally, Zacks Investment Research lowered Phreesia from a "hold" rating to a "sell" rating in a report on Wednesday, April 14th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have given a buy rating to the company. The stock currently has an average rating of "Buy" and an average target price of $53.64.
In other news, CFO Thomas Altier sold 76,272 shares of the stock in a transaction that occurred on Thursday, February 18th. The stock was sold at an average price of $71.96, for a total value of $5,488,533.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Amy Beth Vanduyn sold 21,829 shares of the firm's stock in a transaction that occurred on Friday, January 29th. The stock was sold at an average price of $65.91, for a total value of $1,438,749.39. The disclosure for this sale can be found here. Insiders sold a total of 173,717 shares of company stock worth $11,543,845 in the last three months. Insiders own 28.20% of the company's stock.
A number of institutional investors have recently added to or reduced their stakes in the business. First Horizon Advisors Inc. grew its holdings in shares of Phreesia by 68.9% in the 4th quarter. First Horizon Advisors Inc. now owns 824 shares of the company's stock worth $44,000 after purchasing an additional 336 shares during the last quarter. Advisory Services Network LLC acquired a new stake in shares of Phreesia during the fourth quarter worth approximately $58,000. Nisa Investment Advisors LLC raised its stake in shares of Phreesia by 16.0% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,450 shares of the company's stock valued at $79,000 after acquiring an additional 200 shares during the last quarter. Strs Ohio acquired a new position in shares of Phreesia in the 4th quarter worth approximately $168,000. Finally, Glenview Trust Co bought a new stake in Phreesia during the 4th quarter worth approximately $202,000. Hedge funds and other institutional investors own 75.38% of the company's stock.
Shares of Phreesia stock opened at $53.00 on Wednesday. The company has a current ratio of 7.24, a quick ratio of 7.24 and a debt-to-equity ratio of 0.09. The firm has a fifty day simple moving average of $54.16 and a 200-day simple moving average of $53.91. The stock has a market capitalization of $2.38 billion, a price-to-earnings ratio of -88.33 and a beta of 1.42. Phreesia has a 1-year low of $23.82 and a 1-year high of $81.59.
Phreesia Company Profile
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments.
Recommended Story: What impact do institutional investors have on markets?
Get a free copy of the Zacks research report on Phreesia (PHR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Featured Article: Asset Allocation7 Stocks to Buy As Americans Receive Stimulus Checks
Millions of Americans will be receiving an additional $1,400 as part of the Biden stimulus plan after receiving $600 as part of the stimulus bill that President Trump back on December 27, 2020. Many already have.
For many Americans, there is a definite plan for how that money will be spent. And the usual suspects like Walmart (NYSE:WMT) and Amazon (NASDAQ:AMZN) will likely continue to be busy. However, for other Americans, the money they receive will truly be like finding money. Both scenarios present different thoughts for investors.
You may agree with the payments. You may disagree with them. It really doesn’t matter, they’re coming and now as an investor, the question is how can you benefit from the new spending that will undoubtedly occur as a result of Americans receiving this stimulus?
We have some ideas and we’re sharing them with you in this special presentation. It’s comforting to remember that for many people receiving the stimulus checks will help ease the pressure from desperate circumstances.
View the "7 Stocks to Buy As Americans Receive Stimulus Checks"